Nephrology and Hypertension

Clinical specialties: acute kidney injury, nephrotic syndrome, kidney stones

Visit the Devarajan Lab.

Premedical Studies: Bombay University, India, 1979.

MD: Bombay University, India, 1985.

Pleasant L, Ma Q, Devarajan M, Parameswaran P, Drake K, Siroky B, Shay-Winkler K, Robbins J, Devarajan P. Increased Susceptibility to Structural Acute Kidney Injury in a Mouse Model of Presymptomatic Cardiomyopathy. Am J Physiol Renal Physiol. 2017.

Nehus E, Kaddourah A, Pyles O, Bennett M, Devarajan P. Subclinical Kidney Injury in Children Receiving Nonsteroidal Anti-Inflammatory Drugs after Cardiac Surgery. J Pediatr. 2017.

Dong L, Ma Q, Bennett M, Devarajan P. Urinary Biomarkers of Cell Cycle Arrest are Delayed Predictors of Acute Kidney Injury After Pediatric Cardiopulmonary Bypass. Pediatr Nephrol. 2017.

Bennett MR, Pleasant L, Haffner C, Ma Q, Haffey WD, Ying J, Wagner M, Greis KD, Devarajan P. A Novel Biomarker Panel to Identify Steroid Resistance in Childhood Idiopathic Nephrotic Syndrome. Biomarker Insights. 2017:12.

Soto K, Campos P, Pinto I, Rodrigues B, Frade F, Papoila AL, Devarajan P. The risk of chronic kidney disease and mortality are increased after community-acquired acute kidney injury. Kidney Int. 2016 Nov;90(5):1090-1099.

Schuh MP, Nehus E, Ma Q, Haffner C, Bennett MR, Devarajan P. Long-term Stability of Urinary Biomarkers of Acute Kidney Injury in Children. Am J Kid Dis. 2016;67(1):56-61.

Devarajan P. Genomic and proteomic characterization of acute kidney injury. Nephron. 2015;131(2):85-91.

Zappitelli M, Greenberg JH, Coca SG, Krawczeski CD, Li S, Thiessen-Philbrook HR, Bennett MR, Devarajan P, Parikh CR, for the TRIBE-AKI Consortium. Association of Definition of Acute Kidney Injury by Cystatin C Rise With Biomarkers and Clinical Outcomes in Children Undergoing Cardiac Surgery. JAMA Pediatr. 2015 Jun 1;169(6):583-91.

Bennett MR, Nehus E, Haffner C, Ma Q, Devarajan P. Pediatric reference ranges for acute kidney injury biomarkers. Pediatr Nephrol. 2015 Apr;30(4):677-85.

Devarajan P. NGAL for the Detection of Acute Kidney Injury in the Emergency Room. Biomark Med. 2014 Feb;8(2):217-9.

Faculty

Michael R. Bennett, PhD Director, Biomarker Laboratory

Michael R. Bennett, PhD, research interests include developing early diagnostic markers for pediatric diseases, such as acute kidney injury, nephrotic syndrome and lupus nephritis. Dr. Bennett is also interested in unraveling the etiology of focal segmental glomerulosclerosis by studying both the underlying genetic and proteomic patterns associated with the disease.

513-636-8349 michael.bennett@cchmc.org

High Res

Michael R. Bennett, PhD

Director, Biomarker Laboratory

Academic Affiliations

Assistant Professor, UC Department of Pediatrics

Phone 513-636-8349

Email michael.bennett@cchmc.org

Show All

Research Interests

Diagnostic markers for pediatric diseases; acute kidney injury; nephrotic syndrome; lupus nephritis; focal segmental glomerulosclerosis; mechanisms of neurologic disease

Research Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

PhD: University of Cincinnati College of Medicine, Cincinnati, OH, 2004.

BA: Thomas More College, Crestview Hills, KY, 1997.

Krawczeski C, Vandevoorde R, Kathman T, Bennett M, Woo J, Wang Y, Griffiths R, Devarajan P. Serum Cystatin C Is an Early Predictive Biomarker of Acute Kidney Injury after Pediatric Cardiopulmonary Bypass. CJASN. 2010; 2010 Sep;5(9):1552-7.

Bagshaw SM, Bennett M, Haase M, Haase-Fielitz A, Egi M, Morimatsu H, D'amico G, Goldsmith D, Devarajan P, Bellomo R. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med. 2009;36(3):381-4

Stella CL, Bennett MR, Devarajan P, Greis K, Wyder M, Macha S, Rao M, Jodicke C, Moussa H, How HY, Myatt L, Webster R, Sibai BM. Preterm labor biomarker discovery in serum using 3 proteomic profiling methodologies. Am J Obstet Gynecol. 2009;201(4):387.e1-13.

Haase M, Bellomo R, Devarajan P, Ma Q, Bennett MR, Möckel M, Matalanis G, Dragun D, Haase-Fielitz A. Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults. Ann Thorac Surg. 2009;88(1):124-30

Haase-Fielitz A, Bellomo R, Devarajan P, Bennett M, Story D, Matalanis G, Frei U, Dragun D, Haase M. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant. 2009;24:3349-3354.

Bennett M, Ravipati N, Ross G, Nguyen M, Hirsch R, Beekman R, Rovner L, Devarajan P. Using proteomics to identify pre-procedural risk factors for contrast induced nephropathy. Proteomics – Clinical Applications. 2008;2(7-8):1058-1064.

Koyner JL, Bennett MR, Worcester EM, Ma Q, Raman J, Jeevanandam V, Kasza KE, O'Connor MF, Konczal DJ, Trevino S, Devarajan P, Murray PT. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008;74(8):1059-1069.

Lavery AP, Meinzen-Derr JK, Anderson E, Ma Q, Bennett MR, Devarajan P, Schibler KR. Urinary NGAL in premature infants. Pediatr Res. 2008;64(4):423-8.

Bennett M, Dent C, Ma Q, Dastrala S, Grenier F, Workman R, Syed H, Ali S, Barasch J, Devarajan P. Urine NGAL predicts acute kidney injury, morbidity and mortality after cardiac surgery: a prospective study. Clinical Journal of the American Society of Nephrology. 2008;3(3): 665-673.

Bennett M, Czech K, Arend L, Witte D, Devarajan P, Potter, S. Analysis of the glomerular gene expression profile in patients with focal segmental glomerulosclerosis. Experimental Nephron. 2007;107(1): e30-40

Suzuki M, Ross GF, Wiers K, Nelson S, Bennett MR, Passo MH, Devarajan P, Brunner HI. Identification of a urinary proteomic signature for lupus nephritis. Pediatric Nephrology. 2007;22(12): 2047-2057.

Elif Erkan, MD, MS Pediatric Nephrologist, Division of Nephrology

Elif Erkan, MD, MS, is a physician scientist whose research interests are proteinuria induced injury in the kidney and the mechanism of albumin endocytosis in the proximal tubule epithelial cells. Her laboratory studies the protein-protein interactions between endocytic receptors/adapters and protein kinases that are involved in cell signaling events.

513-636-4531 elif.erkan@cchmc.org

High Res

Elif Erkan, MD, MS

Pediatric Nephrologist, Division of Nephrology

Academic Affiliations

Associate Professor, UC Department of Pediatrics

Phone 513-636-4531

Email elif.erkan@cchmc.org

Show All

Clinical & Research Interests

Clinical

Proteinuria; nephrotic syndrome.

Research

Proteinuria induced tubular injury; tubular apoptosis; albumin endocytosis.

Biography

Dr. Elif Erkan received the prestigious SPR Fellow's Basic Research Award upon completion of her pediatric nephrology fellowship. She pursued a career as a physician scientist and continued to investigate the mechanism of proteinuria induced injury in proximal tubule cells following her fellowship. Her laboratory demonstrated an important link between endocytic adapter protein disabled-2 (Dab2) that binds to the cytoplasmic tail of albumin receptor megalin and protein kinase B (Akt). She received an NIH career development-KO8 award to support her studies elucidating the link between albumin endocytosis and cell signaling events.

MD: Ankara University School of Medicine, Ankara, Turkey, 1990.

Residency: Pediatrics, Marmara University Hospital, Istanbul, Turkey, 1992-1997.

Residency: Pediatrics, Montefiore Medical Center, Albert Einstein School of Medicine, Bronx, NY, 2000-2002.

Fellowship: Pediatric Nephrology, Montefiore Medical Center, Albert Einstein School of Medicine, Bronx, NY, 1997-2000.

MS: Clinical Research Methods Montefiore Medical Center, Albert Einstein School of Medicine, Bronx, NY, 1998-2001.

Erkan E. Proteinuria: It is time to look beyond the proximal tubule. Am J Physiol Renal Physiol. 2013 Oct:305(8):F1107-8.

Erkan E. Proteinuria and progression of glomerular diseases. Pediatr Nephrol. 2013 Jul;28(7):1049-58.

Koral K, Erkan E. Pkb/Akt partners with Dab2 in albumin endocytosis. Am J Physiol Renal Physiol. 2012 Apr 15;302(8): F1013-24.

Keyel PA, Thieman JR, Roth R, Erkan E, Everett ET, Watkins SC, Heuser JE, Traub LM. The AP-2 adaptor beta2 appendage scaffolds alternate cargo endocytosis. Mol Biol Cell. 2008 Dec;19(12):5309-26.

Erkan E, Devarajan P, Schwartz G. Mitochondria are the major targets in albumin induced apoptosis in proximal tubule cells. J Am Soc Nephrol. 2007 Apr;18(4): 1199-208.

Erkan E, Devarajan P, Schwartz G. Apoptotic responses to albumin overload: proximal vs. distal/collecting tubule cells. Am J Nephrol. 2005 Mar-Apr;25(2):121-31.

Erkan E, Garcia C, Patterson LT, Mishra J, Mitsnefes MM, Kaskel FJ, Devarajan P. Induction of renal tubular cell apoptosis in FSGS: Roles of proteinuria and Fas-dependent pathways. J Am Soc Nephrol. 2005 Feb;16(2): 398-407.

Erkan E, Sakarcan A, Haklar G, Yalcin S. Thyroxine prevents reoxygenation injury in isolated proximal tubule cells. Pediatr Nephrol. 2003 Jul;18(7): 636-43.

Erkan E, Devarajan P, Kaskel F. Role of nitric oxide, endothelin-1, and inflammatory cytokines in blood pressure regulation in hemodialysis patients. Am J Kidney Dis. 2002 Jul;40(1):76-8.1

Erkan E, Moritz M, Kaskel F. Impact of residual renal function in children on hemodialysis. Pediatr Nephrol. 2001 Nov;16(11): 858-61.

Stuart L. Goldstein, MD, FAAP, FNKF Clark D. West Endowed Chair

Stuart L. Goldstein, MD, FAAP, FNKF, focuses on all aspects of acute kidney injury (AKI) spanning from translational work in AKI biomarker validation to long-term AKI epidemiology and outcomes. He is specifically interested in improving outcomes in the critically ill child with or at risk for AKI.

513-636-2078 stuart.goldstein@cchmc.org

High Res

Stuart L. Goldstein, MD, FAAP, FNKF

Clark D. West Endowed Chair

Director, Center for Acute Care Nephrology

Medical Director, Pheresis Service

Co-Medical Director, Heart Institute Research Core

Academic Affiliations

Professor, UC Department of Pediatrics

Phone 513-636-2078

Fax 513-636-7407

Email stuart.goldstein@cchmc.org

Show All

Clinical & Research Interests

Clinical

Acute kidney injury; continuous renal replacement therapy; cardio-renal syndrome; nephrotoxic medication associated morbidity

Research

Acute kidney injury epidemiology and biomarkers; heart failure associated chronic kidney disease; nephrotoxic medication associated acute kidney injury reduction

Biography

Stuart L. Goldstein, MD, has been an active investigator in the field of pediatric acute kidney injury (AKI) since 2000. Dr. Goldstein’s main research foci include: AKI epidemiology and outcomes, acute renal replacement therapy provision and investigation of novel urinary AKI biomarkers in the pediatric population. Dr. Goldstein has established a strong record of interdisciplinary and inter-institutional collaboration with cardiologists, intensivists and emergency center physicians, which is evidenced by his establishment and directing of the Prospective Pediatric Continuous Renal Replacement Therapy Registry from 2001 to 2012, and the Prospective Pediatric AKI Research Group (ppAKI-RG) in 2012. The ppAKI-RG is comprised of 52 centers from around the world with the goal of improving outcomes for the child with or at-risk for, AKI.

Dr. Goldstein has led efforts to develop a standardized definition for pediatric AKI, assess novel AKI biomarkers in heterogeneous populations, and conceiving and validating stratification tools to identify patients at risk for AKI. Building upon these findings, Dr. Goldstein embarked on establishing the ppAKI-RG consortium to focus on multi-centered research studies that are dedicated to understanding and treating AKI in pediatric patients. Currently, the ppAKI-RG has completed three major, and unprecedented, national and international studies (AWARE, NINJA and DIRECT) to accurately characterize pediatric AKI epidemiology, reduce AKI and improve patient outcomes. Dr. Goldstein is also a recognized educator; he and his team host the CRRT University™ course, which provides an high-fidelity simulation experience to pediatric and adult CRRT programs from around the country with a faculty of world renowned experts in AKI. In addition he has developed the only pediatric specific acute care nephrology sub-specialty fellowship with graduates who are now leaders in the field of pediatric AKI.

MD: Columbia College of Physicians and Surgeons, New York, NY, 1990.

Residency: Baylor College of Medicine, Houston, TX.

Fellowship: Pediatric Nephrology, Children's Hospital, Boston, MA.

Grants

Clinical Evaluation of the Prismaflex™ HF20 Set and Prismaflex™Control Unit Version 5.10 Software for Acute Continuous Renal Replacement Therapy (CRRT) in Children. Principal Investigator. Gambro Renal Products, Inc. Mar 2014–Mar 2018.

Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care. Principal Investigator. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Trials Network-POPS. Feb 2013–Feb 2018.

Recombinant Erythropoietin Protects Against Kidney Disease. Principal Investigator. National Institutes of Health. Sep 2014–Aug 2019.

Reduction of Nephrotoxic Medication Associated Acute Kidney Injury in Children: Dissemination of a Successful Quality Improvement Project. Principal Investigator. Agency for Healthcare Research and Quality. Apr 2015–Mar 2018.

David K. Hooper, MD, MS Medical Director of Kidney Transplantation

David K. Hooper, MD, MS, aims to improve clinical outcomes for pediatric kidney transplant recipients through research in personalized care and the design of systems capable of delivering that care with high reliability. His primary focus is the prevention of cardiovascular disease through a combination of quality improvement and clinical/translational research methods.

513-636-4531 david.hooper@cchmc.org

High Res

David K. Hooper, MD, MS

Medical Director of Kidney Transplantation

Academic Affiliations

Assistant Professor, UC Department of Pediatrics

Phone 513-636-4531

Fax 513-636-7407

Email david.hooper@cchmc.org

Show All

Nephrology; kidney transplantation; quality improvement

Biography

Jointly appointed in the Division of Nephrology and Hypertension and the James M. Anderson Center for Health Systems Excellence at Cincinnati Children’s Hospital Medical Center within the UC Department of Pediatrics, Dr. Hooper's aim is to improve clinical outcomes for pediatric kidney transplant recipients through research in personalized care and the design of reliable healthcare systems.

Dr. Hooper's research training includes a master's degree in clinical and translational research from the University of Cincinnati, in addition to advanced training in quality improvement methodology through the Quality Scholars in Healthcare Transformation program at Cincinnati Children’s.

Dr. Hooper's career focus is to combine clinical outcomes research with quality improvement to reliably prevent cardiovascular disease, the leading cause of long-term death and disability in pediatric transplant recipients.

MD: University of Utah, Salt Lake City, Utah, 2003.

Residency: Cincinnati Children's Hospital, Cincinnati, Ohio, 2006.

Chief Residency: Cincinnati Children's Hospital, Cincinnati, Ohio, 2007.

MS: University of Cincinnati, Cincinnati, Ohio, 2010.

Fellowship: Cincinnati Children's Hospital, Cincinnati Ohio, 2010; Quality Scholar in Healthcare Transformation, James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital, Cincinnati, Ohio, 2011.

Certification: Pediatrics, 2006.

Hooper DK, Kirby C, Margolis P, Goebel J. Reliable Individualized Monitoring Improves Cholesterol Control in Kidney Transplant Recipients. Pediatrics. 2013 Apr;131(4):e1271-9.

Hooper DK, Williams JC, Carle AC, Amaral S, Chand DH, Ferris ME, Patel HP, Licht C, Barletta GM, Bastian V, Mitsnesfes M, Patel UD. The Quality of Cardiovascular Disease Care and Formal Transition for Adolescents with Kidney Disease. Pediatr Nephrol. 2013 Jun;28(6):939-49.

Hooper DK, Fukuda T, Logan B, Gardiner R, Roy-Chaudhury A, Kirby C, Vinks A, Goebel J. Risk of Tacrolimus Toxicity in CYP3A5 Non-Expressors Treated with Intravenous Nicardipine After Kidney Transplantation. Transplantation. 2012 Apr;93(8):806-812.

Saldaña SN, Hooper DK, Froehlich TE, Campbell KM, Prows CA, Sadhasivam s, Nick TG, Seid M, Vinks AA, Glauser TA. Characteristics of Successful Recruitment in Prospective Pediatric Pharmacogenetic Studies. Clinical Therapeutics. 2011 Feb;15:88-95.

Hooper DK, Carle AC, Schuchter J, Goebel J. Interaction between tacrolimus and intravenous nicardipine in the treatment of post-kidney transplant hypertension at pediatric hospitals. Pediatr Transplant. 2011 Feb;15(1):88-95.

Kaplan HC, Brady PW, Dritz MC, Hooper DK, Linam WM, Froehle CM, Margolis P. The influence of context on quality improvement success in health care: a systematic review of the literature. Milbank Q. 2010 Dec;88(4):500-59.

Hooper DK. The Impact of CYP3A5 Genotype on the Interaction Between Tacrolimus and Intravenous Nicardipine in Kidney Transplant Recipients. University of Cincinnati. 2010 Aug 17.

Hooper DK, Hawkins JA, Fuller TC, Profaizer T, Shaddy RE. Panel-reactive antibodies late after allograft implantation in children. Ann Thorac Surg. 2005 Feb;79(2):641-4.

Raetz EA, Kim MK, Moos P, Carlson M, Bruggers C, Hooper DK, Foot L, Liu T, Seeger R, Carroll WL. Identification of genes that are regulated transcriptionally by Myc in childhood tumors. Cancer. 2003 Aug 15;98(4):841-53.

Lirazan MB, Hooper D, Corpuz GP, Ramilo CA, Bandyopadhyay P, Cruz LJ, Olivera BM. The spasmodic peptide defines a new conotoxin superfamily. Biochemistry. 2000 Feb 22;39(7):1583-8.

Paul T. McEnery, MD, MBA Professor Emeritus

Paul T. McEnery, MD, MBA, has focused his career on the research of membranoproliferative glomerulonephritis and is a key member of the North American Pediatric Renal Transplant Consortium data base. Besides his research in transplantation and immune-mediated renal disease, he also was responsible for bringing the Ronald McDonald House to Cincinnati Children's as well as initiating dialytic therapy for children in Cincinnati.

paul.mcenery@cchmc.org

Paul T. McEnery, MD, MBA

Professor Emeritus

Academic Affiliation

Professor Emeritus, UC Department of Pediatrics

Email paul.mcenery@cchmc.org

Show All

Clinical Interests

Glomerulonephritis; vitamin D resistant rickets; care of the child with end-stage renal disease.

MD: Loyola University, Chicago, IL, 1965.

Residency: Children's Hospital Medical Center, Cincinnati, OH.

Fellowship: Nephrology, Children's Hospital Medical Center, Cincinnati, OH.

Certification: Pediatrics 1974, 1986, 1993; Pediatric Nephrology, 1974, 1986, 1993.

MBA: Xavier University, 1989.

DeFoor W, Tackett L, Minevich E, McEnery P, Kitchens D, Reeves D, Sheldon C. Successful renal transplantation in children with posterior urethral valves. J Urol. 2003 Dec;170(6 Pt 1):2402-4.

Mitsnefes M, Ho PL, McEnery PT. Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). J Am Soc Nephrol. 2003 Oct;14(10):2618-22.

DeFoor W, Minevich E, McEnery P, Tackett L, Reeves D, Sheldon C. Lower urinary tract reconstruction is safe and effective in children with end stage renal disease. J Urol. 2003 Oct;170(4 Pt 2):1497-500; discussion 1500.

Mitsnefes MM, Khoury PR, McEnery PT. Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr. 2003 Jul;143(1):98-103.

Mitsnefes MM, Khoury P, McEnery PT. Body mass index and allograft function in pediatric renal transplantation. Pediatr Nephrol. 2002 Jul;17(7):535-9.

Omoloja AA, Racadio JM, McEnery PT. Post-biopsy renal arteriovenous fistula. Pediatr Transplant. 2002 Feb;6(1):82-5.

Mitsnefes MM, Omoloja A, McEnery PT. Short-term pediatric renal transplant survival: blood pressure and allograft function. Pediatr Transplant. 2001 Jun;5(3):160-5.

Schurman SJ, McEnery PT. Factors influencing short-term and long-term pediatric renal transplant survival. J Pediatr. 1997 Mar;130(3):455-62.

McEnery PT. Pediatric renal transplantation: A review of data from north American pediatric renal transplant cooperative study (NAPRTCS). Saudi J Kidney Dis Transpl. 1994 July-September;5(3):336-46.

McEnery PT, Alexander SR, Sullivan K, Tejani A. Renal transplantation in children and adolescents: the 1992 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol. 1993 Dec;7(6):711-20.

Mark M. Mitsnefes, MD, MS Director, Clinical and Translational Research Center

Mark M. Mitsnefes, MD, MS, is an established clinical investigator with expertise in the area of understanding the development of risk factors for cardiovascular disease in children with chronic kidney disease. The long-term goal of his research is to define biologic targets for interventions to prevent and slow progression of cardiovascular disease in children with chronic kidney disease.

513-636-0125 mark.mitsnefes@cchmc.org

High Res

Mark M. Mitsnefes, MD, MS

Director, Clinical and Translational Research Center

Pediatric Nephrologist, Division of Nephrology

Academic Affiliations

Professor, UC Department of Pediatrics

Phone 513-636-0125

Fax 513-636-7407

Email mark.mitsnefes@cchmc.org

Show All

Nephrology with focus on chronic kidney disease and hypertension

Biography

Mark Mitsnefes, MD, MS, is an established clinical investigator with expertise in the area of understanding the development of risk factors for cardiovascular disease in children with chronic kidney disease. The long-term goal of his research is to define biologic targets for interventions to prevent and slow progression of cardiovascular disease in children with chronic kidney disease.

Dr. Misnefes has received numerous awards, including the Proctor Scolar Award (Cincinnati Children's Research Foundation), the Pediatrician Scientist Award (Children's Health Research Center, NIH), the Clinical Scientist Award (National Kidney Foundation), and has been ranked as one of the Best Doctors in America, 2007-2011.

MD: Gorky Medical Institute, Gorky, Russia, 1985.

Residency: Miami Children's Hospital, Miami, FL, 1997.

Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2000.

MS: Epidemiology and Biostatistics, University of Cincinnati, Cincinnati, OH, 2001.

Certifications: Educational Commission for Foreign Medical Graduates (ECFMG), 1995; Pediatrics, 1996; Pediatric Nephrology, 2001, 2008.

Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, Kimball T, Furth S, Warady B; CKiD Study Group. Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol. 2010 Jan;21(1):137-44.

Wilson AC, Mitsnefes MM. Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management. Am J Kidney Dis. 2009 Aug;54(2):345-60. Review.

Flynn JT, Mitsnefes MM, Pierce C, Cole SR, Parekh RS, Furth SL and Warady BA. Blood pressure in children with chronic kidney disease: Preliminary findings from chronic kidney disease in children cohort study. Hypertension. 2008;52(4):631-7

Weaver DJ Jr, Kimball T, Witt SA, Glascock BJ, Khoury PR, Kartal J, Mitsnefes MM. Subclinical systolic dysfunction in pediatric patients with chronic kidney disease. J Pediatr. 2008 Oct;153(4):565-9.

Weaver DJ Jr., Kimball TR, Knilans T, Mays WK, Knecht T, Gerdes YT, Witt S, Glascock BJ, Kartal J, Khoury PR, and Mitsnefes MM. Decreased maximal aerobic capacity in pediatric chronic kidney disease. J Am Soc Nephrol. 2008, 19(3):624-30.

Mitsnefes MM, Kimball TR, Kimball TR, Witt SA, Glascock BJ, Khoury PR, and Daniels SR. Abnormal carotid artery structure and function in children with successful renal transplant. Circulation. 2004; 110:97-101.

Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock B, Khoury PR, Daniels SR. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: Role of calcium-phosphorus metabolism. J Am Soc Nephrol. 2005;16:2796-2803.

Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glascock BJ, Khoury PR and Daniels SR. Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int. 2004;65(4):1461-1466.

Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, and Daniels SR. Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation. 2003;107:864-868

Mitsnefes MM, Daniels SR, Schwartz SM, Khoury P, Meyer RA, and Strife CF. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol. 2000;14:898-902.

Grants

Cardiovascular disease in children with CKD. Principal Investigator. National Institutes of Health. 2011 - 2016. #K24 DK090070-01.

Edward J. Nehus, MD, MS Pediatric Nephrologist, Division of Nephrology

Edward J. Nehus, MD, MS, is a pediatric nephrologist who has conducted clinical research in chronic kidney disease and critical care nephrology. His primary area of research is studying pharmacokinetic alterations in critically ill children receiving continuous renal replacement therapy. Other research interests include studying cardiovascular risk factors and glomerular filtration rate estimation in children with chronic kidney disease.

513-636-4531 edward.nehus@cchmc.org

High Res

Edward J. Nehus, MD, MS

Pediatric Nephrologist, Division of Nephrology

Academic Affiliations

Assistant Professor, UC Department of Pediatrics

Phone 513-636-4531

Email edward.nehus@cchmc.org

Show All

Critical care nephrology; chronic kidney disease

Biography

Edward conducted and published a cross-sectional study which investigated the association of serum resistin with cardiovascular risk factors in children with chronic kidney disease. In addition, he recently published a study evaluating the outcomes steroid-avoidance protocols in pediatric kidney transplant recipients. He continues to be the primary investigator for ongoing studies that explore pharmacokinetic alterations in critically ill children receiving continuous renal replacement therapy.

MD: University of Toledo, Toledo, OH, 2002.

MS: University of Cincinnati, Cincinnati, OH, 2011.

Residency: Pediatrics, Nationwide Children’s Hospital, Columbus, OH.

Certification: Pediatrics, 2009.

Fellowship: Pediatric Nephrology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH.

Nehus E, Goebel J, Abraham E. Outcomes of steroid-avoidance protocols in pediatric kidney transplant recipients. Am J Transplant. 2012 Dec;12(12):3441-8.

Nehus E, Furth S, Warady B, Mitsnefes M. Correlates of resistin in children with chronic kidney disease: the chronic kidney disease in children cohort. J Pediatr. 161(2): 276-80, 2012.

Nehus E, Goebel J, Mitsnefes M, Lorts A, Laskin B. Intensive hemodialysis for cardiomyopathy associated with end-stage renal disease. Pediatr Nephrol. 26: 1909-12, 2011.

Nehus E, Devarajan P. Acute kidney injury: AKI in kidney transplant recipients—here to stay. Nat Rev Nephrol. 8:198-199, 2012.

Brian J. Siroky, PhD Member, Division of Nephrology

Brian J. Siroky, PhD, focuses on understanding the mechanisms of renal cyst and tumor formation that occur in tuberous sclerosis complex (TSC), and identification of targeted therapies for these lesions. Structural and functional relationships between renal epithelial primary cilia (specialized cellular organelles whose dysfunction is linked to cystogenesis) and mTOR signaling, the pathway that is dysregulated in TSC is also an area of interest.

513-636-4497 brian.siroky@cchmc.org

C. Frederic Strife, MD

C. Frederic Strife, MD, has focused his research career around immune-mediated renal disease and membranoproliferative glomerulonephritis in particular. Furthermore, Dr. Strife also has been active in understanding how to improve the care of the pediatric dialysis patient.

fred.strife@cchmc.org

C. Frederic Strife, MD

Academic Affiliations

Emeritus, UC Department of Pediatrics

Email fred.strife@cchmc.org

Show All

Clinical Interests

Glomerulonephritis; renal tubular disorders; growth failure in chronic renal disease; dialysis

MD: College of Medicine and Dentistry of New Jersey, 1968.

Residency: Pediatrics, Children's Hospital Medical Center, Cincinnati, OH.

Fellowship: Nephrology, Children's Hospital Medical Center, Cincinnati, OH.

Certification: Pediatrics, 1973; Pediatric Nephrology, 1976.